Skip to content

NeuroBalloon™ 7CBD10Recalls & reported problems

Integra LifeSciences Switzerland Sàrl · NeuroBalloon™ NEUROBALLOON™ CATHETER · Class 1

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10381780035343), received between Jan 14, 2022 and Jan 14, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Break1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 14, 2022Break; Break

    A FACILITY REPORTED THAT THE NEURO BALLOON CATHETER (7CBD10) WAS TESTED BEFORE USE ACCORDING TO THE INSTRUCTIONS, BUT THE BALLOON WAS BROKEN DURING USE. NO PATIENT INJURY OR DEATH ALLEGED AND THE EVENT DID NOT LEAD TO AN INCREASE OF SURGERY TIME.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13257857 ↗

Other INSTRUMENT, SURGICAL, NON-POWERED devices

All INSTRUMENT, SURGICAL, NON-POWERED devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page